Funding news · Sep 18, 2026
Penelope Health raises €87M Series C+ led by Thoreau for payer-policy intelligence platform
Penelope Health Raises €87 Million in Series C+ Round
Penelope Health, a London-based health-technology company, has raised €87 million in a Series C+ round. The raise was announced on 18 September 2026 and was led by Thoreau.
What Penelope Health Does
Penelope Health builds a real-time payer-policy intelligence platform for the US healthcare market. The company tracks the coverage rules that American health insurers publish and converts them into structured data.
That structured data is delivered through an API and endpoints designed to be queried by AI assistants. The goal is to let providers and payers instantly check coverage requirements and compare policies across insurers, replacing manual policy research with programmatic access.
According to the company, its platform covers payer policies for the majority of insured Americans, spanning more than 15,000 procedure and drug codes.
The Round
| Detail | Value |
|---|---|
| Round type | Series C+ |
| Amount | €87 million |
| Date | 18 September 2026 |
| Lead investor | Thoreau |
Investor Syndicate
The Series C+ was led by Thoreau, with participation from:
- Bertelsmann Healthcare Investments
- Seedcamp
- Twine Ventures
- Thoreau
The syndicate combines healthcare-focused capital from Bertelsmann Healthcare Investments with venture backing from Seedcamp and Twine Ventures, alongside the lead position taken by Thoreau.
Why the Raise Matters
Payer policy is one of the most persistent sources of friction in the US healthcare system. Coverage rules are published by individual insurers, change over time, and vary across plans and geographies. Providers frequently need to verify whether a given procedure or drug is covered before delivering care, and payers need to compare their own policies against the market.
Penelope Health's approach is to treat those rules as a data problem. By structuring insurer-published coverage rules and exposing them through an API, the company positions itself as infrastructure that both providers and payers can query directly. The explicit support for AI assistant endpoints reflects where healthcare workflows are heading: coverage checks embedded into tools that clinicians and administrative staff already use, rather than requiring a separate lookup process.
The stated coverage footprint — payer policies for the majority of insured Americans across more than 15,000 procedure and drug codes — is the core scale claim behind the platform. Breadth of code coverage is what makes a policy intelligence layer useful across specialties and drug categories rather than in narrow niches.
For acquirers and strategic investors, Penelope Health represents:
- A structured-data asset covering a large share of US payer policies
- API-first distribution, including endpoints built for AI assistant queries
- A customer base spanning both providers and payers
- A London headquarters addressing the US healthcare market
- A syndicate that includes Thoreau, Bertelsmann Healthcare Investments, Seedcamp and Twine Ventures
What to Watch
The Series C+ gives Penelope Health capital to expand its policy coverage and deepen its API and AI-assistant integrations. The key question for the company is how deeply coverage intelligence becomes embedded in provider and payer workflows — whether it remains a reference layer or becomes a default check inside the systems where care and claims decisions are made.
With €87 million led by Thoreau, Penelope Health is now funded to pursue that embedding at scale.